CompletedNCT00183495
Official study titleDeterminants and Manifestation of Illness Behavior in Promoting Treatment Adherence Among Individuals With Bipolar Depression
This study has finished and is no longer accepting participants.
In BeachwoodBipolarityObservational studyAges 18+
- Countries
- United States
- Sponsor
- Case Western Reserve University
CompletedNCT00183703
Official study titleRapid Cycling Bipolar Disorder (RCBPD), Subjective Illness Experience and Gender
This study has finished and is no longer accepting participants.
Multiple locations, including BeachwoodBipolarityObservational studyAges 18+
- Countries
- United States
- Sponsor
- Case Western Reserve University
CompletedNCT00431522
Official study titleProtective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis
This study has finished and is no longer accepting participants.
In IstanbulBipolarityMedication studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Sanofi
CompletedNCT05357859
Official study titleEffect of Vitamin D Supplement for Cognitive Function in Patients With Bipolar Disorder- Randomized Double-Blind Controlled Trial
This study has finished and is no longer accepting participants.
In TaipeiBipolarityPlacebo comparisonAges 20–65
- Countries
- Taiwan
- Sponsor
- Taipei City Hospital
CompletedNCT02750904
Official study titleWeb-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoBipolarityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Fred Hutchinson Cancer Center
CompletedNCT00391235
Official study titleWhite Matter Connectivity in Pediatric Bipolar Disorder: A Diffusion Tensor Imaging Study
This study has finished and is no longer accepting participants.
In MedfordBipolarityObservational studyAges 6–13
- Countries
- United States
- Sponsor
- Cambridge Health Alliance
CompletedNCT00622739
Official study titleZiprasidone in Pediatric Bipolar Disorder: a 6-week, Open-label Comparison of Rapid vs. Slow Dose Titration
This study has finished and is no longer accepting participants.
In DallasBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Baylor College of Medicine
TerminatedNCT01566370
Official study titleZonisamide for Heavy Drinkers With Bipolar Disorder
This study ended early.
In West HavenBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT05741281
Official study titleThe Effect of Physical Exercises Program on Social Functioning, Alexithymia and Sense of Coherence Among Patients With Bipolar Disorders
This study has finished and is no longer accepting participants.
In AlexandriaBipolarityBehavioural study
- Countries
- Egypt
- Sponsor
- Alexandria University
CompletedEUCTR 2007-005959-42
Official study titleA 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Pat...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaBipolarityHistorical research record
- Countries
- France, Austria, Czechia, + 6 others
- Sponsor
- Bristol Myers Squibb International Corporation
CompletedEUCTR 2017-002190-20
Official study titleA Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In CroatiaBipolarityHistorical research record
- Countries
- Croatia
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedEUCTR 2005-002133-13
Official study titleEFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN A DOUBLE-BLIND, FIXED MULTIPLE DOSE, RANDOMIZED, PLACEBO-CONTROLLED, MULTICE...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SpainBipolarityHistorical research record
- Countries
- Spain
- Sponsor
- BIAL - Portela & Ca, S.A.